Serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia

Clinical and Vaccine Immunology

Volumn 17, Issue 1, 2010, Pages 202-203

  Palacio, Amalia Del ^a   Cuétara, Maria Soledad ^b   Llenas García, Jara ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

(1-3) BETA DEXTRO GLUCAN; GLUCAN; UNCLASSIFIED DRUG; BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-D-GLUCAN;

ASSAY; AUTOPSY; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; IMMUNOCOMPROMISED PATIENT; LETTER; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BLOOD; CHEMISTRY; ISOLATION AND PURIFICATION; NOTE; PNEUMOCYSTIS JIROVECI; SERUM;

BETA-GLUCANS; HUMANS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; SERUM;

EID: 74549144472     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00452-09     Document Type: Letter

References (9)

1. Cuétara, M. S., A. Alhambra, F. Chaves, M. D. Moragues, J. Pontón, and A. del Palacio. 2008. Use of a serum (1→3)-β- D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia. Clin. Infect. Dis. 47: 1364-1366.
2. Del Bono, V., A. Mularoni, E. Furfaro, E. Delfino, L. Rosasco, F. Miletich, and C. Viscoli. 2009. Clinical evaluation of a (1→3)-β-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Clin. Vaccine Immunol. 16:1524-1526.
3. Desmet, S., E. Van Wijngaerden, J. Maertens, J. Verhaegen, E. Verbeken, P. De Munter, W. Meersseman, B. Van Meensel, J. Van Eldere, and K. Lagrou. 21 October 2009. Serum (1→3)-β-D-glucan as a diagnostic tool for Pneumocystis jirovecii pneumonia in patients with HIV infection or hematological malignancy. J. Clin. Microbiol. doi:10.1128/JCM. 01756-09.
4. Huang, L., A. Morris, A. H. Limper, and J. M. Beck. 2006. An official ATS workshop summary: recent advances and future directions in Pneumocystis pneumonia (PCP). Proc. Am. Thorac. Soc. 3:655-664.
5. Krajicek, B. J., A. H. Limper, and C. F. Thomas, Jr. 2008. Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia. Curr. Opin. Pulm. Med. 14:228-234.
6. Marty, F. M., S. Koo, J. Bryar, and L. R. Baden. 2007. (1→3)-β-D-Glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann. Intern. Med. 147:70-72.
7. Morris, A., L. A. Kingsley, G. Groner, I. P. Lebedeva, C. B. Beard, and K. A. Norris. 2004. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 18:793-798.
8. Thomas, C. F., Jr., and A. H. Limper. 2004. Pneumocystis pneumonia. N. Engl. J. Med. 350:2487-2498.
9. Wong, M. L., P. Back, G. Candy, G. Nelson, and J. Murray. 2006. Pneumocystis jirovecii pneumonia in African miners at autopsy. Int. J. Tuberc. Lung Dis. 10:756-770.